title: Effects of sequential feeding of β-adrenergic agonists on cull cow performance, carcass characteristics, and mRNA relative abundance.
abstract: The objectives of this study were to determine the effects of supplementation with a single β-adrenergic agonist (β-AA) or a sequence of β-AA on cow performance, carcass characteristics, and mRNA relative abundance of cull cows implanted and fed a concentrate diet. Sixty cull cows were implanted with Revalor-200 (200 mg of trenbolone acetate and 20 mg of estradiol) and assigned to 1 of 4 treatments (n = 15/treatment): CON = fed a concentrate diet only; RH = supplemented with ractopamine-HCl for the last 25 d before slaughter; ZH = supplemented with zilpaterol-HCl for 20 d before a 3-d withdrawal before slaughter; RH + ZH = supplemented with RH for 25 d, followed by ZH for 20 d before a 3-d withdrawal before slaughter. Ractopamine-HCl was supplemented at a dose of 200 mg·animal(-1)·d(-1), and ZH was supplemented at 8.33 mg/kg (100% DM basis) of feed. All cows were fed a concentrate diet for 74 d. Each treatment had 5 cows per pen and 3 replicate pens. Body weights were collected on d 1, 24, 51, and 72. Muscle biopsies from the LM were collected on d 24, 51, and at slaughter from a subsample of 3 cows per pen. Carcass traits were evaluated postslaughter. The 2 ZH treatments averaged 15.3 kg more BW gain, 0.20 kg greater ADG, and 7.8 cm(2) larger LM area than CON and RH treatments, and 21 kg more HCW than CON, but these differences were not significant (P > 0.10), likely due to a sample size of n = 15/treatment. The sequence of RH followed by ZH tended to optimize the combination of HCW, LM area, percent intramuscular fat, and lean color and maturity compared with the ZH treatment. Abundance of β(2)-adrenergic receptor (AR) mRNA was not altered in the RH + ZH treatment during RH supplementation from d 24 to 51 of feeding. However, the abundance of β(2)-AR mRNA increased (P < 0.05) the last 23 d of feeding for the RH treatment and tended (P = 0.10) to increase in ZH cows during ZH supplementation. For all cows, abundance of type IIa myosin heavy chain (MHC-IIa) mRNA decreased (P < 0.05) after 24 d of feeding. Abundance of MHC-IIx mRNA increased (P < 0.05) for ZH and RH + ZH treatments the last 23 d of feeding during ZH supplementation. Although few significant differences were observed in performance or carcass traits, mRNA quantification indicated that β-AA supplementation elicited a cellular response in cull cows. Implanting and feeding cull cows for 74 d, regardless of β-AA supplementation, added economic value by transitioning cows from a cull cow to what is referred to in industry as a white cow market in which cows have white fat resulting from grain feeding.
authors.affiliation: Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Weber
authors.forename: M E
authors.initials: ME
authors.lastname: Dikeman
authors.forename: J A
authors.initials: JA
authors.lastname: Unruh
authors.forename: J R
authors.initials: JR
authors.lastname: Jaeger
authors.forename: L
authors.initials: L
authors.lastname: Murray
authors.forename: T A
authors.initials: TA
authors.lastname: Houser
authors.forename: B J
authors.initials: BJ
authors.lastname: Johnson
mesh_terms: D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000191:economics / Q000494:pharmacology*; D045930:Anabolic Agents / Q000008:administration & dosage / Q000494:pharmacology; D000821:Animal Feed / Q000191:economics; D000818:Animals; D001823:Body Composition / Q000187:drug effects*; D002417:Cattle / Q000502:physiology*; D004338:Drug Combinations; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology; D004967:Estrogens / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D010627:Phenethylamines / Q000008:administration & dosage / Q000191:economics / Q000494:pharmacology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D060888:Real-Time Polymerase Chain Reaction; D011943:Receptors, Adrenergic, beta / Q000235:genetics / Q000378:metabolism; D014204:Trenbolone Acetate / Q000008:administration & dosage / Q000494:pharmacology; D014297:Trimethylsilyl Compounds / Q000008:administration & dosage / Q000191:economics / Q000494:pharmacology*; D015430:Weight Gain
chemical_list: D000318:Adrenergic beta-Agonists; D045930:Anabolic Agents; D004338:Drug Combinations; D004967:Estrogens; D010627:Phenethylamines; D012333:RNA, Messenger; D011943:Receptors, Adrenergic, beta; D014297:Trimethylsilyl Compounds; C475840:Zilpaterol; D004958:Estradiol; C060897:ractopamine; D014204:Trenbolone Acetate